Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls1_0028.txt
Subject: MPOD 3821 CHRONOLOGY
Unit: OTSG
Parent Organization: HSC
Box ID: BX003202
Folder Title: CHRONOLOGY
Document Number: 1
Folder SEQ #: 29
UNCLASSIFIED
appoint CSA as JCS Executive Agent and to charter Joint Service
Committee on Biological Defense.
127. 15 Jul 91 - AdHoc Joint Committee on Biological Defense
(under auspices of DADCSOPS, MG Del Rosso) met with
representatives from Services, Joint Staff and OSD to designate BW
defense a priority requirement, gather intelligence requirements,
and develop lead Services for working group. Set up future
meeting schedule.
128. 31 Jul 91 - DJS Memorandum to Army Operations Deputy
indicating that only one Executive Agent is required in order to
avoid dual chains of responsibility . . . unnecessary to appoint
both a DOD and JCS EA as SECARMY already serving as DOD EA.
129. 16 Aug 91 - Freedom of Information Act request received by
Joint Staff on behalf of the Public Citizen Litigation Group for
information concerning the use of vaccine for botulinum on US
military personnel stationed in the Persian Gulf during ODS.
Joint Staff response indicated that release of certain information
would highlight vulnerabilities and capabilities which could
interfere with ability to respond rapidly in the future to
identified chronic shortages in the industrial base.
130. 26 Aug 91 - DEPSECDEF memorandum directs SECARMY to be
Executive Agent to design an integrated DOD response to BW threats
which includes production and stockpiling of vaccines/antitoxin;
development and fielding appropriate detection systems, protective
and decontamination systems and coordination/issuance of joint BW
defensive doctrine by 30 Sep 91.
131. 29 Aug 91 - Biological Defense Committee Meeting conducted
by MG Del Rosso (AODCSOPS). Attended by Service representatives,
included brief review
of Terms of Reference; updated foreign BW agent threat assessment
(by ; decontamination efforts to include review of
requirements, current and future efforts, funding profiles,
problem areas and timelines; existing biological defense physical
protection programs; detection system working group efforts;
vaccination policy and vaccine production efforts . . . Army's
production capacity is at maximum . . . experiencing problems
obtaining FDA approval due to full scale vaccine production
efforts. MG Del Rosso indicated work groups must continue efforts
to refine issues and establish procedures to enhance communication
across work groups and push vaccination policy issue . . . near
and far-term policy based on production capability. Scheduled
next meeting for 19 Sep.
132. 19 Sep 91 - Second meeting of the Biological Defense
Committee Meeting conducted by MG Del Rosso (AODCSOPS). Attended
2 8
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 33 f:/Week-36/BX003202/CHRONOLOGY/mpod 3821 chronology:1108961508372
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = CHRONOLOGY
Folder Seq # = 29
Subject = MPOD 3821 CHRONOLOGY
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996